Compagnie Lombard Odier SCmA’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.64M | Buy |
73,918
+66,703
| +925% | +$5.34M | 0.06% | 107 |
|
|
2025
Q4 | $688K | Buy |
7,215
+2,000
| +38% | +$196K | 0.01% | 179 |
|
|
2025
Q3 | $509K | Sell |
5,215
-187
| -3% | -$19.4K | 0.01% | 194 |
|
|
2025
Q2 | $580K | Sell |
5,402
-500
| -8% | -$50.6K | 0.01% | 177 |
|
|
2025
Q1 | $595K | Buy |
5,902
+500
| +9% | +$50.3K | 0.01% | 187 |
|
|
2024
Q4 | $483K | Buy |
5,402
+2,302
| +74% | +$203K | 0.01% | 181 |
|
|
2024
Q3 | $260K | Buy |
3,100
+2,285
| +280% | +$180K | ﹤0.01% | 217 |
|
|
2024
Q2 | $62.8K | Buy |
+815
| New | +$59.7K | ﹤0.01% | 318 |
|
|
2023
Q3 | – | Sell |
-11,111
| Closed | -$601K | – | 593 |
|
|
2023
Q2 | $601K | Hold |
11,111
| – | – | 0.02% | 165 |
|
|
2023
Q1 | $556K | Buy |
11,111
+7,811
| +237% | +$368K | 0.01% | 191 |
|
|
2022
Q4 | $153K | Buy |
+3,300
| New | +$143K | ﹤0.01% | 328 |
|
|
2022
Q1 | – | Sell |
-500
| Closed | -$21K | – | 610 |
|
|
2021
Q4 | $21K | Hold |
500
| – | – | ﹤0.01% | 581 |
|
|
2021
Q3 | $22K | Hold |
500
| – | – | ﹤0.01% | 555 |
|
|
2021
Q2 | $21K | Buy |
+500
| New | +$21K | ﹤0.01% | 547 |
|
|
2019
Q4 | – | Sell |
-800
| Closed | -$33K | – | 529 |
|
|
2019
Q3 | $33K | Hold |
800
| – | – | ﹤0.01% | 387 |
|
|
2019
Q2 | $34K | Buy |
+800
| New | +$30.8K | ﹤0.01% | 386 |
|
|
2017
Q4 | – | Sell |
-650
| Closed | -$19K | – | 647 |
|
|
2017
Q3 | $19K | Hold |
650
| – | – | ﹤0.01% | 608 |
|
|
2017
Q2 | $18K | Buy |
+650
| New | +$17.3K | ﹤0.01% | 619 |
|
|
2017
Q1 | – | Sell |
-22,500
| Closed | -$487K | – | 731 |
|
|
2016
Q4 | $487K | Sell |
22,500
-5,000
| -18% | -$109K | 0.01% | 339 |
|
|
2016
Q3 | $654K | Sell |
27,500
-500
| -2% | -$11.9K | 0.02% | 317 |
|
|
2016
Q2 | $654K | Hold |
28,000
| – | – | 0.02% | 312 |
|
|
2016
Q1 | $526K | Sell |
28,000
-9,000
| -24% | -$158K | 0.02% | 338 |
|
|
2015
Q4 | $682K | Buy |
37,000
+22,000
| +147% | +$394K | 0.02% | 279 |
|
|
2015
Q3 | $246K | Sell |
15,000
-11,022
| -42% | -$188K | 0.01% | 380 |
|
|
2015
Q2 | $461K | Sell |
26,022
-7,500
| -22% | -$134K | 0.02% | 313 |
|
|
2015
Q1 | $595K | Sell |
33,522
-7,500
| -18% | -$119K | 0.02% | 288 |
|
|
2014
Q4 | $544K | Sell |
41,022
-14,495
| -26% | -$185K | 0.03% | 250 |
|
|
2014
Q3 | $655K | Buy |
55,517
+19,729
| +55% | +$248K | 0.03% | 265 |
|
|
2014
Q2 | $457K | Sell |
35,788
-14,663
| -29% | -$191K | 0.02% | 347 |
|
|
2014
Q1 | $682K | Buy |
50,451
+7,451
| +17% | +$97.8K | 0.03% | 267 |
|
|
2013
Q4 | $517K | Buy |
+43,000
| New | +$508K | 0.02% | 320 |
|
Other funds holding BSX
VCM
VPM
Compagnie Lombard Odier SCmA's BSX Position: Q1 2026 in Review
Compagnie Lombard Odier SCmA increased its Boston Scientific (BSX) stake by 925% in Q1 2026, buying an estimated $5.34M and bringing the position to 73,918 shares worth $4.64M. The position accounts for 0.06% of the portfolio, ranked #107.
Compagnie Lombard Odier SCmA first reported a position in BSX in Q4 2013 and has held it in 31 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Compagnie Lombard Odier SCmA held 73,918 shares of Boston Scientific worth $4.64M as of Q1 2026.
- Compagnie Lombard Odier SCmA bought 66,703 Boston Scientific shares in Q1 2026, an estimated $5.34M.
- Boston Scientific made up 0.06% of Compagnie Lombard Odier SCmA's portfolio in Q1 2026, its #107 holding.
- Compagnie Lombard Odier SCmA first reported a position in Boston Scientific in Q4 2013 and has held it in 31 quarters since.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.